Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Vitamin D Supplementation in Chronic Spinal Cord Injury
NCT04652544Phase 3Completed
- Sponsor
- Swiss Paraplegic Research
- Start
- May 2021
- Primary completion
- Jan 2024
- Countries
- 1
01
Overview
Phase 3, randomised, double-blind trial (3 arms), sponsored by Swiss Paraplegic Research. Primary endpoint: Serum 25-hydroxyvitamin D concentration. Started May 2021; status: completed.
Beyond the preview
Go deeper on NCT04652544.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT04652544.